Soleno Therapeutics
SLNO
SLNO
216 hedge funds and large institutions have $3.9B invested in Soleno Therapeutics in 2025 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% more funds holding
Funds holding: 165 → 216 (+51)
21% more call options, than puts
Call options by funds: $285M | Put options by funds: $236M
0.62% more ownership
Funds ownership: 118.37% → 118.99% (+0.62%)
Holders
216
Holding in Top 10
19
Calls
$285M
Puts
$236M
Top Buyers
| 1 | +$116M | |
| 2 | +$101M | |
| 3 | +$65.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$55M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$43.1M |
Top Sellers
| 1 | -$155M | |
| 2 | -$131M | |
| 3 | -$47.6M | |
| 4 |
CG
Carlyle Group
Washington,
District of Columbia
|
-$36.7M |
| 5 |
CC
Commodore Capital
New York
|
-$26.8M |